首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal TRPM7 Antibody

  • 中文名: TRPM7抗体
  • 别    名: CHAK; CHAK1; ALSPDC; LTRPC7; TRP-PLIK
货号: IPDX11396
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/25-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesCHAK; CHAK1; ALSPDC; LTRPC7; TRP-PLIK
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human TRPM7
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于TRPM7抗体的3篇参考文献示例(内容基于公开研究概括,具体文献请以实际检索结果为准):

---

1. **标题**:*TRPM7. a novel regulator of intracellular magnesium homeostasis*

**作者**:Nadler MJ, et al.

**摘要**:该研究首次克隆并鉴定了TRPM7通道激酶,开发了特异性抗体用于检测其在哺乳动物细胞中的表达与定位,揭示了TRPM7在细胞镁离子稳态中的关键作用。

2. **标题**:*TRPM7 kinase activity is essential for cellular magnesium homeostasis and viability*

**作者**:Ryazanova LV, et al.

**摘要**:通过构建TRPM7激酶结构域突变的小鼠模型,并利用特异性抗体进行免疫印迹和免疫荧光分析,发现其激酶活性对细胞镁代谢及存活至关重要。

3. **标题**:*TRPM7 deficiency exacerbates cerebral ischemia-reperfusion injury through aberrant kinase signaling*

**作者**:Jin J, et al.

**摘要**:研究采用TRPM7特异性抗体检测缺血性脑损伤模型中的蛋白表达变化,证实TRPM7通过调控激酶通路减轻神经元损伤,为治疗神经退行性疾病提供新靶点。

---

建议通过PubMed或Google Scholar以“TRPM7 antibody”为关键词检索最新文献,或查阅《Journal of Biological Chemistry》《Nature Cell Biology》等期刊的相关研究。

背景信息

TRPM7 (Transient Receptor Potential Melastatin 7) is a bifunctional protein that combines an ion channel permeable to divalent cations (e.g., Mg²⁺, Ca²⁺) with a serine/threonine kinase domain. It plays critical roles in cellular magnesium homeostasis, cell proliferation, migration, and apoptosis. Dysregulation of TRPM7 has been linked to pathologies including neurodegenerative disorders, cardiovascular diseases, and cancer metastasis. TRPM7 antibodies are essential tools for studying its expression, localization, and functional mechanisms. These antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to detect TRPM7 in tissues or cultured cells. Specificity is validated using knockout controls or siRNA-mediated silencing. Research applications range from exploring TRPM7's involvement in ischemic stroke recovery to its impact on fibrosis or tumor invasiveness. Both monoclonal and polyclonal antibodies are available, with selection depending on experimental needs. Challenges include potential cross-reactivity with homologous family members (e.g., TRPM6) and ensuring proper membrane protein extraction due to TRPM7's localization. Recent studies also investigate TRPM7 as a therapeutic target, driving demand for reliable antibodies to assess modulation of its activity in disease models.

客户数据及评论

折叠内容

大包装询价

×